Contact this trialFirst, we need to learn more about you.
Immunomodulator
Combination Therapy for Multiple Myeloma
Recruiting1 awardPhase 2
West Islip, New York
This trial is testing a combination of drugs to treat patients with multiple myeloma that has resisted chemotherapy. One drug, abatacept, may block proteins that protect myeloma cells from chemotherapy. The other drugs, ixazomib citrate and dexamethasone, work in different ways to stop the growth of myeloma cells. The hope is that the combination of these drugs will be more effective than chemotherapy alone.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.